Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/2008
05/07/2008EP1917351A2 Attenuated reovirus
05/07/2008EP1917273A2 Apoe mimetic agents
05/07/2008EP1917258A2 Pyrimidinyl-pyrazole inhibitors of aurora kinases
05/07/2008EP1917252A1 Pyrazine derivatives and use as pi3k inhibitors
05/07/2008EP1917249A1 3-oxo-indazole-squaric acid derivatives
05/07/2008EP1917248A1 1-acyldihydropyrazol derivatives
05/07/2008EP1917247A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments
05/07/2008EP1917027A2 Cleavage of antifolate compounds
05/07/2008EP1917019A2 Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection
05/07/2008EP1917015A1 Novel 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides
05/07/2008EP1917012A1 Cell migration modulating compounds
05/07/2008EP1917011A1 Combinations comprising dmxaa for the treatment of cancer
05/07/2008EP1916896A2 Non-steroidal antiandrogens
05/07/2008EP1725553B1 Tetrahydropyridoindole derivatives
05/07/2008EP1720849B1 Pyranone derivatives useful for treating cancer
05/07/2008EP1711618A4 Methods for detecting markers associated with endometrial disease or phase
05/07/2008EP1701736A4 Therapeutic agents and uses therefor
05/07/2008EP1575963B1 Anti-angiogenetic therapeutic agents
05/07/2008EP1513588B1 Use of new etonogestrel esters
05/07/2008EP1480951B1 Synthesis of indole thiazole compounds as ligands for the ah receptor
05/07/2008EP1467757B1 Use of antibodies against the muc18 antigen
05/07/2008EP1456651B1 Self-assembly molecules
05/07/2008EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
05/07/2008EP1417308B1 Human protooncogene kg-20 and protein encoded therein
05/07/2008EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug
05/07/2008EP1380593B1 Soluble rage protein
05/07/2008EP1365768B1 Use of er-beta selective antagonists as contraceptives
05/07/2008EP1360208B1 Method for the production of cytotoxic anti-cancer antibodies
05/07/2008EP1356036B1 Process and compositions for peptide, protein and peptidomimetic synthesis
05/07/2008EP1299381B1 Substituted quinazoline derivatives and their use as inhibitors
05/07/2008EP1126028B1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
05/07/2008EP1059929B1 Isolated stromal cells for use in the treatment of diseases of the central nervous system
05/07/2008EP0986636B1 Method for generating activated t-cells and antigen-pulsed antigen-presenting cells
05/07/2008EP0956299B1 Peptide antagonists of dp transcription factors
05/07/2008EP0906106B1 Prevention and treatment of colonic adenoma or colonic microadenoma by 6-fluoroursodeoxycholic acid (6-fudca)
05/07/2008CN101175763A Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer
05/07/2008CN101175760A 39-desmethoxy derivatives of rapamycin
05/07/2008CN101175755A N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase
05/07/2008CN101175754A Novel tetrahydro-1h-pyrido [4,3-b] indole derivatives as cb1' receptor ligands
05/07/2008CN101175753A Compounds and compositions as protein kinase inhibitors
05/07/2008CN101175738A Apoptosis promoters
05/07/2008CN101175532A Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone
05/07/2008CN101175495A Combination therapy
05/07/2008CN101173299A Construction and application of tumour targeting gonad correlation viral vectors
05/07/2008CN101173295A Compositions and methods for identifying antigens which elicit an immune response
05/07/2008CN101173294A Gene tiny chain carrier, construction method and application of the same
05/07/2008CN101173285A Gene differentially expressed in breast and bladder cancer and encoded polypeptides
05/07/2008CN101173284A Mouse anti-human ester polyoses acceptor antibody chain variable region gene and use thereof
05/07/2008CN101173283A Mouse anti-human ester polyoses acceptor antibody heavy chain variable region gene and use thereof
05/07/2008CN101173282A Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
05/07/2008CN101173281A Rhabdophis tigrinus uncoupling protein gene -SA and uses thereof
05/07/2008CN101173268A Representation system of antineoplastic medicament epothilones total length gene cluster
05/07/2008CN101173008A Double-function amalgamation protein, preparation method and application thereof
05/07/2008CN101172997A Oligopeptide or its modified compound/derivant and application thereof
05/07/2008CN101172979A Antineoplastic activity canthardin derivant and method of preparing the same
05/07/2008CN101172978A Six-member heterocyclic compounds, prepare method and medical uses of the same
05/07/2008CN101172162A Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds
05/07/2008CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
05/07/2008CN101172156A Traditional Chinese medicine for treating enteron tumour and method for preparing the same
05/07/2008CN101172143A Chinese traditional medicine compound, method for preparing the same and use thereof
05/07/2008CN101172137A Method for high effectively extracting pseudo-purslane saponin by using cavitated suspension extraction and stripping apparatus
05/07/2008CN101172136A Specific medicine specific for carcinoma
05/07/2008CN101172120A Anti-liver cancer gecko Chinese actinidia root compound preparations
05/07/2008CN101172113A Application of Tween 80 injection in substance base and thermotherapy for treating tumour
05/07/2008CN101172112A Compound with special property, composition containing the compound, preparing method and uses of the same
05/07/2008CN101172110A Application of 23-hydroxyl radical white birck acid in preparing medicament for treating or preventing intestinal canal tumour
05/07/2008CN101172107A Percutaneous drug administration cream ,ointment of letrozole and preparation method thereof
05/07/2008CN101172104A Processes of making and using pharmaceutical formulations of antineoplastic agents
05/07/2008CN101172100A Stable isotonic lyophilized protein formulation
05/07/2008CN101172099A Stable isotonic lyophilized protein formulation
05/07/2008CN101171952A Method for extracting jatropha curcas seed endosperm protein
05/07/2008CN100386435C Small interfering RNA for suppressing multiple effect growth factor expression and its uses
05/07/2008CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
05/07/2008CN100386325C Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
05/07/2008CN100386316C Mixtures and compounds from Antrodia camphorate myceliums and use thereof
05/07/2008CN100386314C Pharmaceutical compositions containing azetidine derivatives novel azetidine derivatives and preparation thereof
05/07/2008CN100386115C Anti-cancer medicine composition
05/07/2008CN100386109C Chinese materia medica preparation for treating tumors and cancer
05/07/2008CN100386092C Use of goldenrod herb oil in preparing anti-tumor medicine
05/07/2008CN100386089C Compound lentinan preparation and its preparing method
05/07/2008CN100386085C Fat Emulsion transfusion liquid for preventing and curing tumour and production method thereof
05/07/2008CN100386077C Coated norcantharidin tablet and its preparing method
05/07/2008CN100386074C Retinoic acid and the like oral formulation
05/06/2008US7369946 Crystalline polypeptide for use in the treatment of tumor and cardiovascular and respiratory system disorders
05/06/2008US7368572 Anticancer agents
05/06/2008US7368565 Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
05/06/2008US7368545 PCA3 messenger RNA species in benign and malignant prostate tissues
05/06/2008US7368473 Paclitaxel enhancer compounds
05/06/2008US7368465 Metalloproteinase inhibitors
05/06/2008US7368459 Heterocyclic compounds
05/06/2008US7368440 Methods for the administration of amifostine and related compounds
05/06/2008US7368436 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state
05/06/2008US7368431 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon
05/06/2008US7368428 Contacting tumor cells to glycoprtorein 88 (GP88) antagonists (e.g., anti-GP88 antibodies, anti-GP88 antisense nucleic acids, GP88 siRNA, and small molecules); antiestrogen and cytotoxic therapy
05/06/2008US7368295 Nanoparticles comprising biologically active TNF which is immobilized on the same
05/06/2008US7368287 For treatment and/or prevention of inflammation and autoimmune disease; vaccines
05/06/2008US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
05/06/2008US7368255 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders
05/06/2008US7368254 Lipid-based systems for targeting diagnostic agents
05/06/2008US7368244 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics
1 ... 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 ... 2211